Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HME1 | BMS-265246 | 0.031622777 | 0.1260 | 0.17111 |
| HME1 | BMS-265246 | 0.1 | 0.0773 | 0.22717 |
| HME1 | BMS-265246 | 0.1 | 0.1057 | 0.26620 |
| HME1 | BMS-265246 | 0.1 | 0.0681 | 0.21395 |
| HME1 | BMS-265246 | 0.316227766 | -0.0287 | 0.34246 |
| HME1 | BMS-265246 | 0.316227766 | -0.0294 | 0.33601 |
| HME1 | BMS-265246 | 0.316227766 | -0.0226 | 0.25425 |
| HME1 | BMS-265246 | 1.0 | 0.0516 | 0.24204 |
| HME1 | BMS-265246 | 1.0 | -0.0398 | 0.28443 |
| HME1 | BMS-265246 | 1.0 | -0.0693 | 0.36937 |
| HME1 | BMS-265246 | 3.16227766 | -0.0206 | 0.27938 |
| HME1 | BMS-265246 | 3.16227766 | -0.0547 | 0.38150 |
| HME1 | BMS-265246 | 3.16227766 | 0.0026 | 0.23639 |
| HME1 | BMS-265246 | 10.0 | 0.0372 | 0.26230 |
| HME1 | BMS-265246 | 10.0 | 0.0652 | 0.26492 |
| HME1 | BMS-265246 | 10.0 | 0.0773 | 0.27047 |
| HME1 | Ulixertinib | 0.001 | 0.9679 | -0.00623 |
| HME1 | Ulixertinib | 0.001 | 1.0281 | 0.00155 |
| HME1 | Ulixertinib | 0.001 | 0.9472 | -0.00104 |
| HME1 | Ulixertinib | 0.003162278 | 0.8624 | 0.04277 |
| HME1 | Ulixertinib | 0.003162278 | 0.9986 | 0.00241 |
| HME1 | Ulixertinib | 0.003162278 | 0.8548 | 0.01121 |
| HME1 | Ulixertinib | 0.01 | 0.8816 | 0.05225 |
| HME1 | Ulixertinib | 0.01 | 0.9488 | 0.03027 |
| HME1 | Ulixertinib | 0.01 | 0.8446 | 0.01650 |